EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combining Cyclic Triimidazo Triazine Core With Ethynyl‐ N ‐Methyl‐Pyridinium Groups for Targeting G‐Quadruplex Structures

Chiara Platella, Stefano Di Ciolo, Andrea Criscuolo, Daniele Malpicci, Rosa Gaglione, Angela Arciello, Domenica Musumeci, Elena Lucenti, Elena Cariati, Daniela Montesarchio iD, Clelia Giannini

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Chiara Platella und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, University of Naples Federico II, Napoli, Italy. Hauptthemen laut MEDLINE: G-Quadruplexes, Triazines, Pyridinium Compounds, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The research leading to these results has received funding from: (i) Fondazione AIRC under IG 2020-ID.25046- P.I. Montesarchio Daniela; (ii) CN00000041 Nationa…, This study is supported by Università degli Studi di Milano: PSR2022_DIP_005_PI_CGIAN..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The synthesis and characterization of a mini‐library of cyclic triimidazo triazine ( TT ) derivatives functionalized with one, two, or three ethynyl‐ N ‐methyl‐pyridinium moieties are reported here. These compounds were designed with the aim of targeting cancer‐related DNA G‐quadruplex structures. The newly synthesized compounds were tested for their ability to bind G‐quadruplexes from both telomeric and oncogene promoter sequences using an affinity chromatography‐based assay, spectroscopic and electrophoretic techniques, as well as molecular docking analysis. The obtained results demonstrated the effective capacity of the investigated compounds to specifically recognize the selected G‐quadruplex models, with their TT cores targeting the outer G‐quartets and their positively charged N ‐methyl‐pyridinium groups interacting with the top edge of G‐quadruplex grooves. Notably, the trisubstituted cyclic triimidazole compounds showed higher stabilizing properties than the related disubstituted derivatives, which in turn were stronger binders than their monosubstituted analogs. However, the mono‐ and disubstituted derivatives showed higher G‐quadruplex versus duplex recognition selectivity compared with the trisubstituted ones. Altogether, the biophysical experiments, also in agreement with the biological assays, underlined the advantage of introducing an alkyne linker between the triimidazole core and the methylpyridinium group, proving to be beneficial to increase both the stabilizing effects on the G‐quadruplexes and the anticancer activity compared with the analogs of the same family lacking the alkyne linker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-QuadruplexesTriazinesPyridinium CompoundsAntineoplastic AgentsStructure-Activity RelationshipHumansMolecular StructureMolecular Docking Simulation

Stichwörter der Autor:innen

G‐quadruplex ligandsantiproliferative activitybiophysical characterizationchemical synthesiscyclic triimidazo triazine derivatives

Substanzen

TriazinesPyridinium CompoundsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemical Sciences, University of Naples Federico II, Napoli, Italy.
  • Department of Chemistry, University of Milan, Milano, Italy.
  • Institute of Biostructures and Bioimaging (IBB) - CNR, Napoli, Italy.
  • Institute of Chemical Sciences and Technologies "Giulio Natta" (SCITEC) of CNR, Milano, Italy.

ORCID-Profile: Daniela Montesarchio

Förderung

  • The research leading to these results has received funding from: (i) Fondazione AIRC under IG 2020-ID.25046- P.I. Montesarchio Daniela; (ii) CN00000041 Nationa…
  • This study is supported by Università degli Studi di Milano: PSR2022_DIP_005_PI_CGIAN.

Zitieren

APA

Platella, C., Di Ciolo, S., Criscuolo, A., Malpicci, D., Gaglione, R., Arciello, A., Musumeci, D., Lucenti, E., Cariati, E., Montesarchio, D., & Giannini, C. (2025). Combining Cyclic Triimidazo Triazine Core With Ethynyl‐ N ‐Methyl‐Pyridinium Groups for Targeting G‐Quadruplex Structures. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70037

Vancouver

Platella C, Di Ciolo S, Criscuolo A, Malpicci D, Gaglione R, Arciello A, et al. Combining Cyclic Triimidazo Triazine Core With Ethynyl‐ N ‐Methyl‐Pyridinium Groups for Targeting G‐Quadruplex Structures. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70037

BibTeX
@article{Platella2025,
  author = {Platella, Chiara and Di Ciolo, Stefano and Criscuolo, Andrea and Malpicci, Daniele and Gaglione, Rosa and Arciello, Angela and Musumeci, Domenica and Lucenti, Elena and Cariati, Elena and Montesarchio, Daniela and Giannini, Clelia},
  title = {Combining Cyclic Triimidazo Triazine Core With Ethynyl‐ N ‐Methyl‐Pyridinium Groups for Targeting G‐Quadruplex Structures},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70037}
}
Kostenlos starten →